NO305834B1 - 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number
NO305834B1
NO305834B1 NO960392A NO960392A NO305834B1 NO 305834 B1 NO305834 B1 NO 305834B1 NO 960392 A NO960392 A NO 960392A NO 960392 A NO960392 A NO 960392A NO 305834 B1 NO305834 B1 NO 305834B1
Authority
NO
Norway
Prior art keywords
mercaptobenzoylguanidines
pharmaceuticals
compounds
manufacture
compound
Prior art date
Application number
NO960392A
Other languages
English (en)
Other versions
NO960392D0 (no
NO960392L (no
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO960392D0 publication Critical patent/NO960392D0/no
Publication of NO960392L publication Critical patent/NO960392L/no
Publication of NO305834B1 publication Critical patent/NO305834B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Testing Resistance To Weather, Investigating Materials By Mechanical Methods (AREA)
NO960392A 1995-01-31 1996-01-30 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler NO305834B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502895A DE19502895A1 (de) 1995-01-31 1995-01-31 4-Mercapto-benzoylguanidin-Derivate

Publications (3)

Publication Number Publication Date
NO960392D0 NO960392D0 (no) 1996-01-30
NO960392L NO960392L (no) 1996-08-01
NO305834B1 true NO305834B1 (no) 1999-08-02

Family

ID=7752677

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960392A NO305834B1 (no) 1995-01-31 1996-01-30 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler

Country Status (27)

Country Link
US (1) US5696167A (no)
EP (1) EP0725062B1 (no)
JP (1) JP3770947B2 (no)
CN (1) CN1058001C (no)
AR (1) AR002954A1 (no)
AT (1) ATE202088T1 (no)
AU (1) AU706843B2 (no)
BR (1) BR9600263A (no)
CA (1) CA2168319C (no)
CO (1) CO4700519A1 (no)
CZ (1) CZ290184B6 (no)
DE (2) DE19502895A1 (no)
DK (1) DK0725062T3 (no)
ES (1) ES2159652T3 (no)
FI (1) FI960423A (no)
GR (1) GR3036344T3 (no)
HU (1) HUP9600213A3 (no)
NO (1) NO305834B1 (no)
PL (1) PL181311B1 (no)
PT (1) PT725062E (no)
RU (1) RU2162079C2 (no)
SI (1) SI0725062T1 (no)
SK (1) SK281199B6 (no)
TR (1) TR199600067A2 (no)
TW (1) TW432036B (no)
UA (1) UA43345C2 (no)
ZA (1) ZA96701B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN1328452A (zh) * 1998-11-26 2001-12-26 默克专利股份公司 苯甲酰基胍类治疗非胰岛素依赖性糖尿病的用途
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
AR061478A1 (es) 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ES2108144T3 (es) * 1992-02-15 1997-12-16 Hoechst Ag Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
TW250479B (no) * 1992-12-15 1995-07-01 Hoechst Ag
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
BR9600263A (pt) 1997-12-23
ZA96701B (en) 1997-04-16
ES2159652T3 (es) 2001-10-16
NO960392D0 (no) 1996-01-30
HUP9600213A2 (en) 1997-01-28
FI960423A0 (fi) 1996-01-30
HU9600213D0 (en) 1996-03-28
EP0725062B1 (de) 2001-06-13
RU2162079C2 (ru) 2001-01-20
JPH08245560A (ja) 1996-09-24
PL312544A1 (en) 1996-08-05
UA43345C2 (uk) 2001-12-17
SI0725062T1 (en) 2001-12-31
SK281199B6 (sk) 2001-01-18
PL181311B1 (pl) 2001-07-31
CZ27796A3 (en) 1996-10-16
CZ290184B6 (cs) 2002-06-12
CN1134413A (zh) 1996-10-30
NO960392L (no) 1996-08-01
HUP9600213A3 (en) 1998-07-28
JP3770947B2 (ja) 2006-04-26
FI960423A (fi) 1996-08-01
GR3036344T3 (en) 2001-11-30
SK12896A3 (en) 1996-09-04
ATE202088T1 (de) 2001-06-15
AR002954A1 (es) 1998-05-27
DE19502895A1 (de) 1996-08-01
PT725062E (pt) 2001-11-30
CN1058001C (zh) 2000-11-01
CA2168319A1 (en) 1996-08-01
DK0725062T3 (da) 2001-09-24
TR199600067A2 (tr) 1996-08-21
AU706843B2 (en) 1999-06-24
CO4700519A1 (es) 1998-12-29
AU4220096A (en) 1996-08-08
US5696167A (en) 1997-12-09
DE59607055D1 (de) 2001-07-19
EP0725062A1 (de) 1996-08-07
CA2168319C (en) 2007-03-06
TW432036B (en) 2001-05-01

Similar Documents

Publication Publication Date Title
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
DK0807111T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
NO306725B1 (no) Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO973608D0 (no) Nye farnesyl-transferaseinhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO923434L (no) 1,2-dihydro-2-oksopyridiner, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst en slik forbindelse
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
NO980059D0 (no) Nye oksazolidinonderivater, fremgangsmåte for fremstilling av dem, samt medikamenter som inneholder disse forbindelsene
BR9606674B1 (pt) novo derivado de composto de antraciclina e preparação farmacêutica contendo o mesmo.
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
IS1885B (is) Þíól afleiður með málmpeptíðasa letjandi virkni, aðferð til framleiðslu þeirra, lyfjaefnablöndur sem innihalda slíkt efnasamband, ásamt notkun á efnasamböndunum til framleiðslu á lyfjum
NO305836B1 (no) Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305793B1 (no) 4-aminobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
NO983540D0 (no) Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering
NO305834B1 (no) 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
DK0727417T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og anvendelse af farmaceutiske præparater på grundlag af disse forbindelser samt lægemidler, der indeholder dem